Different IOL calculators provided similar results in patients with a history of LASIK surgery, according to a study ...

GENEVA, December 09, 2025--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that it has entered into an amended merger ...

Alcon has raised its offer to acquire STAA by 10% to $30.75 per share. STAA's major shareholder, with a 30% stake, intends to vote against the acquisition, stating that the price still significantly ...

Dec 9 (Reuters) - Swiss eyecare giant Alcon (ALCC.S), opens new tab has made a new offer for Staar Surgical (STAA.O), opens new tab worth $1.6 billion, it said on Tuesday, as it seeks to clinch a deal ...

If you have been wondering whether Alcon is quietly becoming a bargain or still priced for perfection, you are in the right place to unpack what the current share price really implies. Over the last ...

Alcon AG reported on Dec. 9 that it had sweetened its offer for intraocular lens maker Staar Surgical Co., raising its offer by roughly 10% to $30.75 a share from its prior bid of $28 a share. The ...

Geneva, Switzerland-based eye care company Alcon has upped its bid to purchase competitor Staar Surgical, increasing its offer from $1.5 to $1.6 billion amid ongoing opposition to the deal. The new ...

In this podcast, experts Tanner Ferguson, MD, and Taj Nasser, MD, FWCRS, discuss the management of astigmatism at the time of ...

Broadwood Partners said it is continuing to oppose Alcon's proposed acquisition of Staar Surgical, despite the prospective buyer increasing its offer. The activist investor Broadwood, which owns 30.2% ...

We are writing to share with you our continued opposition to the proposed transaction. After reviewing the announcements by STAAR and Alcon regarding the course and closing of the 30-day go-shop ...

LAKE FOREST, Calif. - STAAR Surgical Company (NASDAQ:STAA) announced Monday that its go-shop period has expired without receiving any competing acquisition proposals, validating its decision to ...

An overview of the top 10 stories from Optometry Times in 2025.